The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Janna Schneppenheim - , Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)
  • Ralf Dressel - , Georg-August-Universität Göttingen (Autor:in)
  • Susann Hüttl - , Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)
  • Renate Lüllmann-Rauch - , Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)
  • Michael Engelke - , Georg-August-Universität Göttingen (Autor:in)
  • Kai Dittmann - , Georg-August-Universität Göttingen (Autor:in)
  • Jürgen Wienands - , Georg-August-Universität Göttingen (Autor:in)
  • Eeva Liisa Eskelinen - , University of Helsinki (Autor:in)
  • Irm Hermans-Borgmeyer - , Universität Hamburg (Autor:in)
  • Regina Fluhrer - , Ludwig-Maximilians-Universität München (LMU), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) (Autor:in)
  • Paul Saftig - , Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)
  • Bernd Schröder - , Institut für Physiologische Chemie, Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)

Abstract

Regulated intramembrane proteolysis is a central cellular process involved in signal transduction and membrane protein turnover. The presenilin homologue signalpeptide- peptidase-like 2a (SPPL2a) has been implicated in the cleavage of type 2 transmembrane proteins. We show that the invariant chain (li, CD74) of the major histocompatability class II complex (MHCII) undergoes intramembrane proteolysis mediated by SPPL2a. B lymphocytes of SPPL2a,-/- mice accumulate an N-terminal fragment (NTF) of CD74, which severely impairs membrane traffic within the endocytic system and leads to an altered response to B cell receptor stimulation, reduced BAFF-R surface expression, and accumulation of MHCII in transitional developmental stage T1 B cells. This results in significant loss of B cell subsets beyond the T1 stage and disrupted humoral immune responses, which can be recovered by additional ablation of CD74. Hence, we provide evidence that regulation of CD74-NTF levels by SPPL2a is indispensable for B cell development and function by maintaining trafficking and integrity of MHCII-containing endosomes, highlighting SPPL2a as a promising pharmacological target for depleting and/or modulating B cells.

Details

OriginalspracheEnglisch
Seiten (von - bis)41-58
Seitenumfang18
FachzeitschriftJournal of Experimental Medicine
Jahrgang210
Ausgabenummer1
PublikationsstatusVeröffentlicht - Jan. 2013
Peer-Review-StatusJa

Externe IDs

PubMed 23267015

Schlagworte

ASJC Scopus Sachgebiete